SCHEMBL24718243

SCHEMBL24718243

COc1ccc(O)c(C(=O)NC2CC(=O)N(Cc3ccccc3C(F)(F)F)C2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 3/20 0.45
▸ MEN1 O00255 5/20 0.45
▸ KMT2A Q03164 5/20 0.45
▸ RIPK1 Q13546 1/20 0.45
▸ RAB9A P51151 2/20 0.45
▸ P2RX1 P51575 1/20 0.42
▸ TMPRSS4 Q9NRS4 1/20 0.42
▸ ALDH1A1 P00352 4/20 0.42
▸ MAPT P10636 2/20 0.42
▸ TDP1 Q9NUW8 2/20 0.42
▸ ALOX15 P16050 1/20 0.42
▸ KDM4E B2RXH2 3/20 0.41
▸ LMNA P02545 2/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ EPHX2 P34913 1/20 0.41
▸ KCNH2 Q12809 2/20 0.40
▸ HTT P42858 1/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ ALOX12 P18054 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24718415 0.88 TP53 (0.49) TP53MEN1KMT2ARIPK1RAB9A
SCHEMBL24718416 0.87 TP53 (0.46) TP53MEN1KMT2ARIPK1TMPRSS4
SCHEMBL24718382 0.87 TP53 (0.46) TP53MEN1KMT2ARIPK1TMPRSS4
SCHEMBL24718659 0.87 MEN1 (0.46) TP53MEN1KMT2ARIPK1P2RX1
SCHEMBL24718241 0.87 TP53 (0.46) TP53MEN1KMT2ARIPK1TMPRSS4
SCHEMBL24718281 0.87 TP53 (0.46) TP53MEN1KMT2ARIPK1RAB9A
SCHEMBL24718834 0.87 TP53 (0.46) TP53MEN1KMT2ARIPK1RAB9A
SCHEMBL24718645 0.86 TP53 (0.45) TP53MEN1KMT2ARIPK1TMPRSS4
SCHEMBL24719134 0.86 NPC1 (0.47) TP53MEN1KMT2ARIPK1RAB9A
SCHEMBL24718637 0.86 TP53 (0.49) TP53MEN1KMT2ARIPK1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220363633-A1 SUBSTITUTED PYRROLIDONES AND PIPERIDONES AS SMALL MOLECULE INHIBITORS OF EZH2 AND EED PROTEIN BINDING UNITED STATES GOVERNMENT 2022-11-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220363633-A1 SUBSTITUTED PYRROLIDONES AND PIPERIDONES AS SMALL MOLECULE INHIBITORS OF EZH2 AND EED PROTEIN BINDING EED, EZH2, ELP1 TP53 284/4885MEN1 3534/4885KMT2A 180/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback